These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8973787)

  • 1. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
    Ikenaga H; Suzuki H; Saruta T
    Blood Press Suppl; 1992; 3():75-9. PubMed ID: 1343295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
    Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders.
    Mizuno K; Haga H; Takahashi M; Watanabe Y; Fukuchi S
    Blood Press Suppl; 1992; 3():119-23. PubMed ID: 1343279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
    He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
    Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M; Horton C
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S70-5. PubMed ID: 2441189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a calcium channel blocker, manidipine hydrochloride, on the regulatory mechanism of glomerular capillary pressure in SHR.
    Onuki T
    Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):119-26. PubMed ID: 7752503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
    Kimura K; Tojo A; Hirata Y; Hayakawa H; Goto A; Omata M
    Blood Press Suppl; 1994; 5():71-4. PubMed ID: 7889206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of manidipine on renal blood flow and sympathetic nerve activity in conscious, spontaneously hypertensive rats.
    Takishita S; Muratani H; Kawazoe N; Tozawa M; Kimura Y; Fukiyama K
    Blood Press Suppl; 1992; 3():53-9. PubMed ID: 1343291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.